Illumina provides an innovative portfolio of NGS systems, products, and services for many phases of the drug development pipeline.
Pharmacogenomics, the study of how variations in the human genome affect our response to medications, may help reduce adverse drug reactions and medical costs.
Explore innovative genomic analysis solutions designed to inform drug discovery efforts and support development of targeted therapeutics.